Newsroom | Takeda Pharmaceuticals U.S.A., Inc

RSS Feeds

December 20, 2011
FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
December 7, 2011
FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide for Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
November 23, 2011
Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
November 18, 2011
U.S. Food and Drug Administration (FDA) Delays Review of Takeda’s Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
November 17, 2011
DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate)
November 11, 2011
Affymax and Takeda Report Additional Analyses of peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
November 1, 2011
Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
October 25, 2011
Takeda Launches ACTOSInfo.com to Provide Easily Accessible and Accurate Information Regarding ACTOS (pioglitazone HCl)
October 18, 2011
Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
September 27, 2011
American Association of Clinical Endocrinologists and Takeda Launch Diabetes Navigator Website
August 4, 2011
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
July 25, 2011
Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
July 12, 2011
Top U.S. Hypertension Hot Spots Revealed
June 28, 2011
Pit Crew Chiefs Todd Berrier and Kevin 'Bono' Manion Set Aside Rivalry and Team Up to Help Racing Fans Learn More About Gout
June 28, 2011
Late Breaking Data Presented at the American Diabetes Association 71st Annual Scientific Sessions Evaluate the Safety and Tolerability of TAK-875, Takeda’s Investigational Compound for the Treatment of Type 2 Diabetes
June 15, 2011
Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
June 10, 2011
Takeda Responds to French Health Products Safety Agency Announcement Regarding ACTOS (pioglitazone HCl)
May 31, 2011
AFFYMAX AND TAKEDA ANNOUNCE THE SUBMISSION OF A NEW DRUG APPLICATION FOR PEGINESATIDE FOR THE TREATMENT OF ANEMIA ASSOCIATED WITH CHRONIC RENAL FAILURE IN PATIENTS ON DIALYSIS
May 23, 2011
Data from Phase 3 Studies of Investigational Fixed-Dose Combination of Azilsartan Medoxomil Plus Chlorthalidone Presented at the American Society of Hypertension Annual Scientific Meeting
April 28, 2011
Affymax and Takeda Report Additional Phase 3 Clinical Trial Data for Peginesatide in Dialysis Patients at the National Kidney Foundation Spring Clinical Meetings
April 15, 2011
EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients with Hypertension
April 5, 2011
New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix® (clopidogrel bisulfate)
March 23, 2011
Affymax and Takeda to Present Additional Peginesatide Phase 3 Data in Dialysis Patients at the National Kidney Foundation (NKF) 2011 Spring Clinical Meeting
March 23, 2011
New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
March 22, 2011
Critical Need Identified for Patient Guidance on Navigating Online
March 14, 2011
Takeda’s Donation to Aid Earthquake Relief Efforts in Japan
February 25, 2011
FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
February 23, 2011
Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
February 15, 2011
Takeda Enters Into Global Strategic Partnerships with Covance and Quintiles
January 26, 2011
New Patient and Physician Survey Regarding Controlling Hypertension Reveals Areas of Conflicting Perceptions and Attitudes
January 7, 2011
Sucampo and Takeda Initiate Third Phase 3 Clinical Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction

News and Press Releases 2011